Showing results (101-110 of 153) with videos related to
Sort By:
Pageof 16
The Journal of Antibiotics|October 1, 1990
Cytotoxic, antiviral indolocarbazoles from a blue-green alga belonging to the NostocaceaeG Knübel, L K Larsen, R E Moore, et al.Cancer Research|July 15, 1994
Cryptophycin: a new antimicrotubule agent active against drug-resistant cellsC D Smith, X Zhang, S L Mooberry, et al.Journal of the American Chemical Society|June 8, 2001
Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majusculaH Luesch, W Y Yoshida, R E Moore, et al.Molecular Pharmacology|February 1, 1995
Welwitindolinone analogues that reverse P-glycoprotein-mediated multiple drug resistanceC D Smith, J T Zilfou, K Stratmann, et al.Journal of Natural Products|July 28, 2001
Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1H Luesch, R E Moore, V J Paul, et al.Health Affairs (Project Hope)|January 1, 1997
Children's access to mental health care: does insurance matter?S Glied, C W Hoven, R E Moore, et al.American Journal of Public Health|December 1, 1994
Lifetime and five-year prevalence of homelessness in the United StatesB G Link, E Susser, A Stueve, et al.The Journal of Biological Chemistry|December 30, 2000
The role of the FRE family of plasma membrane reductases in the uptake of siderophore-iron in Saccharomyces cerevisiaeC W Yun, M Bauler, R E Moore, et al.Gene Therapy|April 30, 2010
Mass spectrometry measurement of a therapeutic peptide for use in multiple sclerosisJ M Dadgari, R E Moore, K A Louie, et al.The Journal of Pediatrics|June 1, 1988
Relationship of type I procollagen to corticosteroid therapy in children with inflammatory bowel diseaseJ S Hyams, R E Moore, A M Leichtner, et al.Pageof 16